AU752714B2 - Combined preparation of anti-infectiously active compounds which inhibit the 2-C-methylerythrose-4 metabolic pathway, and inhibitors of lipid metabolism - Google Patents

Combined preparation of anti-infectiously active compounds which inhibit the 2-C-methylerythrose-4 metabolic pathway, and inhibitors of lipid metabolism Download PDF

Info

Publication number
AU752714B2
AU752714B2 AU46155/99A AU4615599A AU752714B2 AU 752714 B2 AU752714 B2 AU 752714B2 AU 46155/99 A AU46155/99 A AU 46155/99A AU 4615599 A AU4615599 A AU 4615599A AU 752714 B2 AU752714 B2 AU 752714B2
Authority
AU
Australia
Prior art keywords
substituted
unsubstituted
alkyl
radicals
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU46155/99A
Other languages
English (en)
Other versions
AU4615599A (en
Inventor
Hassan Jomaa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioagency AG
Original Assignee
Jomaa Pharmaka GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19828097A external-priority patent/DE19828097A1/de
Application filed by Jomaa Pharmaka GmbH filed Critical Jomaa Pharmaka GmbH
Publication of AU4615599A publication Critical patent/AU4615599A/en
Assigned to JOMAA PHARMAKA GMBH reassignment JOMAA PHARMAKA GMBH Alteration of Name(s) of Applicant(s) under S113 Assignors: JOMAA, HASSAN
Application granted granted Critical
Publication of AU752714B2 publication Critical patent/AU752714B2/en
Assigned to BIOAGENCY AG reassignment BIOAGENCY AG Alteration of Name(s) in Register under S187 Assignors: JOMAA PHARMAKA GMBH
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/527—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
AU46155/99A 1998-06-24 1999-06-23 Combined preparation of anti-infectiously active compounds which inhibit the 2-C-methylerythrose-4 metabolic pathway, and inhibitors of lipid metabolism Ceased AU752714B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE19828097A DE19828097A1 (de) 1998-06-24 1998-06-24 Kombinationspräparat von Aminohydrocarbylphosphonsäurederivaten und Hemmern des Fettstoffwechsels
DE19828097 1998-06-24
DE19843279 1998-09-22
DE19843279 1998-09-22
PCT/EP1999/004360 WO1999066875A2 (de) 1998-06-24 1999-06-23 Kombinationspräparat von antiinfektiös wirkenden verbindungen, die den 2-c-methylerythrose-4-stoffwechselweg hemmen, und hemmern des fettstoffwechsels

Publications (2)

Publication Number Publication Date
AU4615599A AU4615599A (en) 2000-01-10
AU752714B2 true AU752714B2 (en) 2002-09-26

Family

ID=26047010

Family Applications (1)

Application Number Title Priority Date Filing Date
AU46155/99A Ceased AU752714B2 (en) 1998-06-24 1999-06-23 Combined preparation of anti-infectiously active compounds which inhibit the 2-C-methylerythrose-4 metabolic pathway, and inhibitors of lipid metabolism

Country Status (10)

Country Link
EP (1) EP1100510A2 (de)
JP (1) JP2002518418A (de)
CN (1) CN1348374A (de)
AU (1) AU752714B2 (de)
CA (1) CA2334645A1 (de)
IL (1) IL139965A0 (de)
PL (1) PL345513A1 (de)
SK (1) SK19612000A3 (de)
TR (1) TR200003783T2 (de)
WO (1) WO1999066875A2 (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7132268B2 (en) 1998-04-14 2006-11-07 Kyowa Hakko Kogyo Co., Ltd. Process for producing isoprenoid compounds by microorganisms and a method for screening compounds with antibiotic or weeding activity
WO2015127259A1 (en) * 2014-02-23 2015-08-27 Fmc Corporation Use of 3-isoxazolidinones compounds as selective herbicides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4330529A (en) * 1978-02-15 1982-05-18 Fujisawa Pharmaceutical Co., Ltd. Antibacterial composition
JPS6064991A (ja) * 1983-09-17 1985-04-13 Fujisawa Pharmaceut Co Ltd セファレキシン・ホスミドマイシン塩およびその製造法
US4846872A (en) * 1986-08-11 1989-07-11 Fujisawa Pharmaceutical Co., Ltd. Herbicide
JPH05163150A (ja) * 1991-05-13 1993-06-29 E R Squibb & Sons Inc アテローム性動脈硬化症の抑制・治療剤
ATE129407T1 (de) * 1991-10-11 1995-11-15 Squibb & Sons Inc Verwendung von biphosphonaten zur herstellung eines arzneimittels zur blockierung neoplastischer zelltransformationen die durch ras-oncogene verursacht werden.

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7132268B2 (en) 1998-04-14 2006-11-07 Kyowa Hakko Kogyo Co., Ltd. Process for producing isoprenoid compounds by microorganisms and a method for screening compounds with antibiotic or weeding activity
US7208298B2 (en) 1998-04-14 2007-04-24 Kyowa Hakko Kogyo Co., Ltd. Process for producing isoprenoid compounds by microorganisms and a method for screening compounds with antibiotic or weeding activity
US7364885B2 (en) 1998-04-14 2008-04-29 Kyowa Hakko Kogyo Co., Ltd. Process for producing isoprenoid compounds by microorganisms and a method for screening compounds with antibiotic or weeding activity
US7531333B2 (en) 1998-04-14 2009-05-12 Kyowa Hakko Kogyo Co., Ltd. Process for producing isoprenoid compounds by microorganisms and a method for screening compounds with antibiotic or weeding activity
WO2015127259A1 (en) * 2014-02-23 2015-08-27 Fmc Corporation Use of 3-isoxazolidinones compounds as selective herbicides
EA029969B1 (ru) * 2014-02-23 2018-06-29 Фмк Корпорейшн Применение 3-изоксазолидиноновых соединений в качестве селективных гербицидов

Also Published As

Publication number Publication date
EP1100510A2 (de) 2001-05-23
CA2334645A1 (en) 1999-12-29
AU4615599A (en) 2000-01-10
IL139965A0 (en) 2002-02-10
TR200003783T2 (tr) 2001-06-21
PL345513A1 (en) 2001-12-17
JP2002518418A (ja) 2002-06-25
CN1348374A (zh) 2002-05-08
SK19612000A3 (sk) 2001-08-06
WO1999066875A2 (de) 1999-12-29
WO1999066875A3 (de) 2000-09-14

Similar Documents

Publication Publication Date Title
AU747407B2 (en) Use of organophosphoric compounds for the therapeutic and preventative treatment of infections
US6812224B2 (en) Phosphorous organic compounds and their use
US6753324B2 (en) Phosphorous organic compounds and their use
AU752714B2 (en) Combined preparation of anti-infectiously active compounds which inhibit the 2-C-methylerythrose-4 metabolic pathway, and inhibitors of lipid metabolism
AU5981199A (en) Use of organophosphorous compounds for producing medicaments for the therapeuticand prophylactic treatment of infections or as a fungicide, bactericide or herb icide for plants
CA2360661A1 (en) Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections
CA2399947A1 (en) Phosphororganic compounds and the use thereof
US20030144249A1 (en) Use of organophosphorous compounds for producing a medicament for treating infections
WO2000017212A1 (de) Phosphororganische verbindungen und ihre verwendung
CZ20004797A3 (cs) Kombinovaný přípravek antiinfekčně působících sloučenin, které inhibují metabolickou dráhu 2- C-methylerythrosy-4, a inhibitorů metabolismu lipidů
AU2003261554A1 (en) Organophosphorus containing preparations and applications therefor
CZ2001989A3 (cs) Použití fosfororganických sloučenin pro výrobu léčiv pro terapeutické a profylaktické ošetřování infekcí nebo jako fungicid, baktericid či herbicid u rostlin
MXPA01000488A (en) Phosphorous organic compounds and their use
CZ20003499A3 (cs) Použití organofosforových sloučenin k léčbě a profylaxi infekcí
MXPA01002979A (en) Use of organophosphorous compounds for producing medicaments for the therapeutic and prophylactic treatment of infections or as a fungicide, bactericide or herbicide for plants
CZ2001151A3 (cs) Fosfororganické sloučeniny a jejich použití

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: JOMAA PHARMAKA GMBH

Free format text: THE FORMER OWNER WAS: JOMAA HASSAN

FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: BIOAGENCY AG

Free format text: FORMER OWNER WAS: JOMAA PHARMAKA GMBH